Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Thorax logoLink to Thorax
. 1968 Nov;23(6):571–581. doi: 10.1136/thx.23.6.571

Incidence of serious complications of corticosteroid therapy in respiratory disease

A retrospective survey of patients in the Brompton Hospital

H C Smyllie 1,1, C K Connolly 1,2
PMCID: PMC471854  PMID: 5304705

Abstract

A retrospectively controlled study is described of mortality and serious morbidity in 550 patients treated with corticosteroids and 499 controls. The overall incidence of side-effects was similar in both groups, but gastro-intestinal bleeding, diabetes, and mental disturbance early in treatment occurred more frequently in the corticosteroid group. Other individual side-effects did not occur significantly more often than in the controls, but there was an overall increased frequency of complications with increased dose, and also an increased mortality with increase in the maintenance dose. Gastro-intestinal bleeding was not related to a past or present chronic peptic ulcer, and was not commoner in treated patients. Reactivation of tuberculosis and exacerbation of mental disturbance did not occur. Weight gain occurred in 29% of patients, but appeared to be related closely to a satisfactory response to treatment. Hypertension occurred in 4% of the treated group. Overall mortality in the two groups was similar. Mortality due specifically to corticosteroids was difficult to assess: two patients died of haematemesis and three died with severe asthma during withdrawal of treatment, but there was no increase in mortality following physical stress in the treated series. Sudden death in asthmatics was not more frequent in corticosteroid-treated patients. All seven control patients who died suddenly with asthma were middleaged. Increase in duration of treatment was not associated with increased risk. Indeed the long-term, low-dose group had a lower incidence of complications than the rest and a mortality similar to that of the controls. A trial of corticosteroids for less than one month carried no risk in 41 patients.

Full text

PDF
571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLANBY K. D. Deaths associated with steroid-hormone therapy; an analysis of 18 cases. Lancet. 1957 Jun 1;272(6979):1104–1110. doi: 10.1016/s0140-6736(57)91679-3. [DOI] [PubMed] [Google Scholar]
  2. ANDERSSON E., KJERULF K. Adrenal cortical function during steroid therapy. Acta Med Scand. 1961 May;169:577–582. doi: 10.1111/j.0954-6820.1961.tb07867.x. [DOI] [PubMed] [Google Scholar]
  3. Amatruda T. T., Jr, Hurst M. M., D'Esopo N. D. Certain endocrine and metabolic facets of the steroid withdrawal syndrome. J Clin Endocrinol Metab. 1965 Sep;25(9):1207–1217. doi: 10.1210/jcem-25-9-1207. [DOI] [PubMed] [Google Scholar]
  4. BYWATERS E. G., SCOTT J. T. THE NATURAL HISTORY OF VASCULAR LESIONS IN RHEUMATOID ARTHRITIS. J Chronic Dis. 1963 Aug;16:905–914. doi: 10.1016/0021-9681(63)90139-5. [DOI] [PubMed] [Google Scholar]
  5. Baroody N. B., Baroody W. G. Adrenocorticosteroids in acute myocardial infarction. Am J Med Sci. 1965 Oct;250(4):402–passim. doi: 10.1097/00000441-196510000-00006. [DOI] [PubMed] [Google Scholar]
  6. CHARPIN J., PAYAN H., LUCCIONI R., LIEUTAUD R., OHRESSER P., NICOLINO J. ESSAI D''EVALUATION DU RISQUE OSSEUX CHEZ LES ASTHMATIQUES SOUMIS AU TRAITEMENT CORTISONIQUE AU LONG COURS. Sem Hop. 1963 Oct 14;39:2129–2140. [PubMed] [Google Scholar]
  7. DALL J. L., BUCHANAN J. Steroid therapy in heart-block following myocardial infarction. Lancet. 1962 Jul 7;2(7245):8–12. doi: 10.1016/s0140-6736(62)92930-6. [DOI] [PubMed] [Google Scholar]
  8. DAVIS T. A., ZELLER M. Multiple peptic ulcers with massive hemorrhage during oral cortisone therapy; report of a case. J Am Med Assoc. 1952 Sep 6;150(1):31–31. doi: 10.1001/jama.1952.63680010004008c. [DOI] [PubMed] [Google Scholar]
  9. DEMARTINI F., GROKOEST A. W., RAGAN C. Pathological fractures in patients with rheumatoid arthritis treated with cortison. J Am Med Assoc. 1952 Jun 21;149(8):750–752. doi: 10.1001/jama.1952.02930250032011. [DOI] [PubMed] [Google Scholar]
  10. EISENMENGER W. J., SLATER R. J., BONGIOVANNI A. M. Hypercoagulability of the blood of patients with hepatic cirrhosis following administration of ACTH. Am J Med. 1952 Jul;13(1):27–34. doi: 10.1016/0002-9343(52)90078-8. [DOI] [PubMed] [Google Scholar]
  11. ELLIOTT J. M., CARBONE J. V. The longterm treatment of ulcerative colitis with hydrocortisone, prednisone and prednisolone. Gastroenterology. 1957 Sep;33(3):423–433. [PubMed] [Google Scholar]
  12. HENNEMAN P. H., WANG D. M., IRWIN J. W., BURRAGE W. S. Syndrome following abrupt cessation of prolonged cortisone therapy. J Am Med Assoc. 1955 Jun 4;158(5):384–386. doi: 10.1001/jama.1955.02960050026006. [DOI] [PubMed] [Google Scholar]
  13. HILBISH T. F., BLACK R. L. X-ray manifestations of peptic ulceration during corticosteroid therapy of rheumatoid arthritis. AMA Arch Intern Med. 1958 May;101(5):932–942. doi: 10.1001/archinte.1958.00260170088012. [DOI] [PubMed] [Google Scholar]
  14. KIRSNER J. B., PALMER W. L., SPENCER J. A., BICKS R. O., JOHNSON C. F. Corticotropin (ACTH) and the adrenal steroids in the management of ulcerative colitis: observations in 240 patients. Ann Intern Med. 1959 Apr;50(4):891–927. doi: 10.7326/0003-4819-50-4-891. [DOI] [PubMed] [Google Scholar]
  15. KIRSNER J. B., SKLAR M., PALMER W. L. The use of ACTH, cortisone, hydrocortisone and related compounds in the management of ulcerative colitis; experience in 180 patients. Am J Med. 1957 Feb;22(2):264–274. doi: 10.1016/0002-9343(57)90010-4. [DOI] [PubMed] [Google Scholar]
  16. KNOWLES J. P. Difficulties in weaning in steroid treatment in asthma. Br Med J. 1961 Nov 25;2(5264):1396–1399. doi: 10.1136/bmj.2.5264.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LERNER L. J., BIANCHI A., TURKHEIMER A. R., SINGER F. M., BORMAN A. ANTI-INFLAMMATORY STEROIDS: POTENCY, DURATION AND MODIFICATION OF ACTIVITIES. Ann N Y Acad Sci. 1964 Aug 27;116:1071–1077. doi: 10.1111/j.1749-6632.1964.tb52569.x. [DOI] [PubMed] [Google Scholar]
  18. McCANCE R. A. Overnutrition and undernutrition. I. Causes. Lancet. 1953 Oct 3;265(6788):685–690. doi: 10.1016/s0140-6736(53)90417-6. [DOI] [PubMed] [Google Scholar]
  19. Nicholson H. The management of asthma. Practitioner. 1965 Dec;195(170):742–748. [PubMed] [Google Scholar]
  20. OLESEN K. H., QUAADE F. Pneumothorax accompanying staphylococcal pneumonia in patients treated with steroids. Lancet. 1961 Mar 11;1(7176):535–536. doi: 10.1016/s0140-6736(61)91602-6. [DOI] [PubMed] [Google Scholar]
  21. OZSOYLU S., STRAUSS H. S., DIAMOND L. K. Effects of corticosteroids on coagulation of the blood. Nature. 1962 Sep 22;195:1214–1215. doi: 10.1038/1951214a0. [DOI] [PubMed] [Google Scholar]
  22. PARKER R. A., THOMAS P. M. Intestinal perforation and widespread arteritis in rheumatoid arthritis during treatment with cortisone. Br Med J. 1959 Feb 28;1(5121):540–542. doi: 10.1136/bmj.1.5121.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. PEARSON R. S., BAYLIS J. H., SMELLIE H. C. Treatment of chronic asthma with prednisolone and the newer steroids. Br Med J. 1961 Feb 4;1(5222):315–319. doi: 10.1136/bmj.1.5222.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. REES H. A., WILLIAMS D. A. Long-term steroid therapy in chronic intractable asthma. A study of 317 adult asthmatics on continuous steroid therapy for an average period of 2 1/2 years. Br Med J. 1962 Jun 9;1(5292):1575–1579. doi: 10.1136/bmj.1.5292.1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. RILEY C. M., SCAGLIONE P. R. Current management of nephrosis statistical evaluation and a proposed approach to therapy. Pediatrics. 1959 Mar;23(3):561–569. [PubMed] [Google Scholar]
  26. ROSEMAN D. L., ECONOMOU S. G. TREATMENT OF COMPLICATIONS OF GASTRODUODENAL "STEROID ULCERS". Arch Surg. 1965 Apr;90:488–494. doi: 10.1001/archsurg.1965.01320100032006. [DOI] [PubMed] [Google Scholar]
  27. Thorn G. W. Clinical considerations in the use of corticosteroids. N Engl J Med. 1966 Apr 7;274(14):775–781. doi: 10.1056/NEJM196604072741406. [DOI] [PubMed] [Google Scholar]
  28. VAUGHAN V. C., 3rd DIAGNOSIS AND TREATMENT: USE OF STEROIDS IN ASTHMA IN CHILDREN. Pediatrics. 1965 Jan;35:113–117. [PubMed] [Google Scholar]
  29. WALTON J. N. SOME DISEASES OF MUSCLE. Lancet. 1964 Feb 29;1(7331):447–452. doi: 10.1016/s0140-6736(64)90792-5. [DOI] [PubMed] [Google Scholar]
  30. Walsh S. D., Grant I. W. Corticosteroids in treatment of chronic asthma. Br Med J. 1966 Oct 1;2(5517):796–802. doi: 10.1136/bmj.2.5517.796. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES